Series B - Edico Genome

Series B - Edico Genome

Investment Firm

Overview

Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy.

Announced Date

May 09, 2017

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Dell Technologies Capital

Dell Technologies Capital

Dell Technologies Capital is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

4

Investor Name
Participant InvestorAxon Ventures
Participant InvestorFusionX Ventures
Participant InvestorQualcomm Ventures
Participant InvestorDell Technologies Capital

Round Details and Background

Edico Genome raised $22000000 on 2017-05-09 in Series B

Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2014
Series A - Edico Genome
1-undefined
May 09, 2017
Series B - Edico Genome
5-22.0M
Apr 17, 2013
Non Equity Assistance - Edico Genome
1-undefined
Jul 17, 2014
Series A - Edico Genome
5-10.0M

Recent Activity

There is no recent news or activity for this profile.